News Room

Follow:
55875 Articles

Regeneron Pharmaceuticals Gets FDA OK for High-Dose Eylea Eye Treatment

By Will Feuer Regeneron Pharmaceuticals said the Food and Drug Administration has approved an eight-milligram injection of its Eylea treatment

Midday movers: Ross Stores, Applied Materials, Deere and more

© Reuters Investing.com -- U.S. stocks are mixed on Friday, heading toward a down week as investors fretted over the

Legal Action Contemplated by Binance Following Termination of Partnership with Checkout.com

On August 17, Binance, the world's largest cryptocurrency exchange, received notification from payment processor Checkout.com about the termination of their

Shopify: Soaring Profits With A 2-Pronged Approach (NYSE:SHOP)

The Shopify Investment Thesis Appears Bright, Thanks To The Two Pronged Approach We previously covered Shopify (NYSE:SHOP) in May 2023,

Stocks to Watch: Palo Alto Networks, NAPCO Security, Maui Land & Pineapple

By Will Feuer Palo Alto Networks reported a jump in earnings for its fiscal fourth quarter and issued upbeat guidance

4 big analyst cuts: Farfetch downgraded on disappointing Q2, Cigna slashed to Hold

© Reuters. Here is your Pro Recap of the biggest analyst cuts you may have missed since yesterday: Downgrades at

Your one-stop resource for medical news and education.

Your one-stop resource for medical news and education.